Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
N
Nectar Lifesciences Ltd
Score 68/100• Decent
Nectar Lifesciences Ltd shows potential in a growing sector, but faces challenges in consistency and valuation, warranting cautious observation.
Company’s Health27/100
Valuation 100/100 · PB 0.3073
Technical Avoid
1M -11.111% 6M -43.013% 1Y -60.941%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#76
View details ➜
M
Makers Laboratories Ltd
Score 68/100• Decent
Makers Laboratories Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
Company’s Health64/100
Valuation 100/100 · PB 0.704
Technical Avoid
1M -2.245% 6M -13.062% 1Y -9.252%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#77
View details ➜
L
Laurus Labs Ltd
Score 68/100• Decent
Laurus Labs Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics.
Company’s Health68/100
Valuation 20/100 · PB 10.8363
Technical Watch
1M 2.552% 6M 43.517% 1Y 107.109%
Confidence100%
Weak ROEPromoter pledge present
#78
View details ➜
J
Jubilant Pharmova Ltd
Score 68/100• Decent
Jubilant Pharmova Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
Company’s Health54/100
Valuation 60/100 · PB 2.9016
Technical Avoid
1M 4.197% 6M 17.42% 1Y 0.952%
Confidence100%
Low leverage (D/E)Decent revenue growth
Promoter pledge present
#79
View details ➜
J
Jagsonpal Pharmaceuticals Ltd
Score 68/100• Decent
Jagsonpal Pharmaceuticals Ltd shows potential but faces significant challenges in profitability and valuation metrics. Caution is advised for investors.
Company’s Health94/100
Valuation 20/100 · PB 6.1603
Technical Avoid
1M -9.742% 6M -9.912% 1Y 12.815%
Confidence100%
Low leverage (D/E)No promoter pledge
#80
View details ➜
J
J B Chemicals and Pharmaceuticals Ltd
Score 68/100• Decent
J B Chemicals and Pharmaceuticals Ltd shows decent potential with a stable growth outlook, but investors should be cautious of execution risks and valuation metrics.
Company’s Health95/100
Valuation 20/100 · PB 7.7119
Technical Avoid
1M -0.42% 6M 5.786% 1Y -10.278%
Confidence100%
Low leverage (D/E)No promoter pledge
#81
View details ➜
I
IPCA Laboratories Ltd
Score 68/100• Decent
IPCA Laboratories Ltd shows potential for growth, but investors should be cautious due to profitability inconsistencies and valuation concerns.
Company’s Health80/100
Valuation 40/100 · PB 3.8753
Technical Avoid
1M -7.652% 6M -12.243% 1Y -19.751%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#82
View details ➜
I
Indoco Remedies Ltd
Score 68/100• Decent
Indoco Remedies Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health56/100
Valuation 60/100 · PB 2.6045
Technical Avoid
1M -6.788% 6M 17.789% 1Y -10.909%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#83
View details ➜
H
Hindustan Bio Sciences Ltd
Score 68/100• Decent
Hindustan Bio Sciences Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health33/100
Valuation 20/100 · PB 9.2257
Technical Avoid
1M -13.523% 6M -19.78% 1Y -48.632%
Confidence100%
No promoter pledgeHealthy profit margins
Weak ROEHigh debt/equity
#84
View details ➜
G
Gufic Biosciences Ltd
Score 68/100• Decent
Gufic Biosciences Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
Company’s Health90/100
Valuation 20/100 · PB 5.8336
Technical Avoid
1M -7.333% 6M -11.131% 1Y -21.655%
Confidence100%
No promoter pledge
#85
View details ➜
F
Fortis Healthcare Ltd
Score 68/100• Decent
Fortis Healthcare Ltd shows potential in a growing sector but faces challenges in execution and competition. Caution is advised.
Company’s Health67/100
Valuation 20/100 · PB 9.0395
Technical Momentum
1M 8.213% 6M 55.192% 1Y 77.135%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#86
View details ➜
D
Dr Lalchandani Labs Ltd
Score 68/100• Decent
Dr Lalchandani Labs Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation metrics. Caution is advised.
Company’s Health46/100
Valuation 100/100 · PB 0.989
Technical Avoid
1M 7.868% 6M 84.219% 1Y 15.758%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#87
View details ➜
D
DocMode Health Technologies Ltd
Score 68/100• Risky
DocMode Health Technologies Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health44/100
Valuation 40/100 · PB 4.3322
Technical Momentum
1M 92.928% 6M 123.642% 1Y 30.915%
Confidence100%
Weak ROEPromoter pledge present
#88
View details ➜
C
Concord Biotech Ltd
Score 68/100• Decent
Concord Biotech Ltd shows potential for growth but faces challenges in valuation and execution risks.
Company’s Health94/100
Valuation 20/100 · PB 8.7861
Technical Avoid
1M -6.877% 6M -10.674% 1Y -18.758%
Confidence100%
Low leverage (D/E)No promoter pledge
#89
View details ➜
B
Bharat Parenterals Ltd
Score 68/100• Decent
Bharat Parenterals Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health64/100
Valuation 60/100 · PB 2.605
Technical Avoid
1M -6.558% 6M 28.706% 1Y -9.27%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#90
View details ➜
Showing 76 to 90 of 260 (18 Pages)